DENVER, Dec. 7, 2022 /PRNewswire/ — Palantir Technologies Inc. (NYSE: PLTR) today announced that the Centers for Disease Control and Prevention (CDC) has renewed its work with the company to continue delivering leading-edge software and digital capabilities to modernize the nation’s public health infrastructure. Using the Palantir platform, the agency will be able to employ scalable technology to plan, manage, and respond to future outbreaks and public health incidents. 

This five year, $443M contract will streamline Palantir’s existing programs – including Health and Human Services (HHS) Protect, Administration for Strategic Preparedness and Response (ASPR) Engage, Tiberius, and DCIPHER – into a singular, efficient vehicle. This new approach demonstrates the CDC’s leadership in driving inter-agency public health, and the length of the contract allows for long-term planning and operational consistency for the program and its partners. 

Under this deal, Palantir’s technology will support the CDC’s “Common Operating Picture”, a unique inter-agency enterprise investment that secures strong collaboration across the federal government, jurisdictional health departments, private sector entities, and other key health partners. By employing Palantir’s software, these groups can continue to make advances in broader disease surveillance and outbreak response, supply chain resiliency, and the orchestration of medical countermeasures to public health emergencies. For example, this award will help support innovation for the CDC’s new Center for Forecasting and Outbreak Analytics (CFA), as well as wastewater genomics via the National Wastewater Surveillance System (NWSS).

Over the last several years, significant technology investments have been made for pandemic preparedness, emergency response, integrated public health surveillance, supply chain management, and inter-agency coordination to create a modern public health infrastructure. Palantir’s technology played an integral role in the federal government’s response to COVID-19, and this partnership aims to leverage the lessons learned during that time and translate them into a more generalized pandemic preparedness infrastructure and healthcare system in the U.S.

“Palantir is extremely proud to continue its partnership with the CDC, ASPR, and HHS to strengthen America’s public health infrastructure through leading-edge preparedness technology,” said Hirsh Jain, Head of Public Health, Federal at Palantir. “This contract solidifies the important digital advancements in public health made during the pandemic and expands the CDC’s capacity to create a sustainable and long-term approach beyond COVID-19.”

This deal is the latest example of Palantir’s role in the U.S. and global public health sector.

About Palantir Technologies Inc.

Foundational software of tomorrow. Delivered today. Additional information is available at

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir’s expectations regarding the amount and the terms of the contract and the expected benefits of our software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include our ability to meet the unique needs of our customer; the failure of our platforms to satisfy our customer or perform as desired; the frequency or severity of any software and implementation errors; our platforms’ reliability; and our customer’s ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings we make with the Securities and Exchange Commission from time to time. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

Media Contact 
Lisa Gordon, [email protected]



By admin

Leave a Reply

Your email address will not be published. Required fields are marked *